Freedom from daily dosing with long-acting injectables.
Pets are family. Don’t they deserve the best care?
The Future of Veterinary Medicine
Freedom from daily dosing with long-acting injectibles.
Pets are family. Don’t they deserve the best care?
Imagine if there were a way to administer medication to dogs and cats that require long-term treatment without any involvement from pet parents.
Leveraging drug delivery technology developed to treat humans, we are reformulating pills and topicals into long-acting injectables (LAIs) to replace the demands of daily dosing. We are harnessing the power of this drug delivery platform to address chronic conditions in cats and dogs with the vision of developing LAIs to treat other species of animals.
Our products will give comfort to pets and freedom to pet parents. Placement of the injectable is quick and easily done in a process similar to the placement of a tracking chip. After the treatment course is finished, the injectable is safely absorbed.
Advantages of Long-Acting Injectables
- Relief from the demands of daily dosing
- Prescription compliance guarantee
- Improved quality of care
- Prevention of drug abuse and diversion
- Reduced environmental burden
Our first product LS-001 is a long-acting injectable medication to control pain associated with bone cancer in dogs. The active ingredient in LS-001 is a well-established medication commonly prescribed for both humans and animals, meeting the safety and effectiveness criteria for conditional approval. Lifescient is seeking funding to advance the development of LS-001.
Download our company presentation